Annis Gardner Whiting Capital Advisors, LLC Ionis Pharmaceuticals Inc Transaction History
Annis Gardner Whiting Capital Advisors, LLC
- $357 Billion
- Q4 2024
A detailed history of Annis Gardner Whiting Capital Advisors, LLC transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Annis Gardner Whiting Capital Advisors, LLC holds 10,736 shares of IONS stock, worth $354,610. This represents 0.11% of its overall portfolio holdings.
Number of Shares
10,736
Previous 9,936
8.05%
Holding current value
$354,610
Previous $398 Million
5.7%
% of portfolio
0.11%
Previous 0.11%
Shares
3 transactions
Others Institutions Holding IONS
# of Institutions
412Shares Held
140MCall Options Held
829KPut Options Held
789K-
Vanguard Group Inc Valley Forge, PA16.5MShares$544 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD14.2MShares$468 Million0.31% of portfolio
-
Capital World Investors Los Angeles, CA11.5MShares$379 Million0.06% of portfolio
-
Black Rock Inc. New York, NY10.3MShares$341 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA8.67MShares$286 Million0.06% of portfolio
About IONIS PHARMACEUTICALS INC
- Ticker IONS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,940,992
- Market Cap $4.69B
- Description
- Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...